PPIDT00201

Drug Information
NameTeprotumumab
SequenceNot Available
DrugBank_IDDB06343
Typebiotech
IndicationTeprotumumab is indicated for the treatment of thyroid eye disease regardless of disease activity or duration.[L45899]
Dosage Forms
Form Route Strength
Injection, powder, lyophilized, for solution Intravenous
500 mg/1
Injection, powder, lyophilized, for solution Intravenous
50000000 mg
Target Information
Role Uniprot_ID Gene_Name Entity_Name Organism Actions Internal link
target P08069 IGF1R Insulin-like growth factor 1 receptor Homo sapiens binder|antibody Link